Literature DB >> 6466296

gamma-butyrobetaine in tissues and serum of fed and starved rats determined by an enzymic radioisotopic procedure.

H Noël, R Parvin, S V Pande.   

Abstract

A method for the determination of picomole quantities of gamma-butyrobetaine and its application for the determination of gamma-butyrobetaine distribution in tissues are described. The method is based on the quantitative conversion of gamma-butyrobetaine into carnitine by using a 50-60%-satd.-(NH4)2SO4 fraction of rat liver supernatant as the source of gamma-butyrobetaine hydroxylase [4-trimethylaminobutyrate,2-oxoglutarate:oxygen oxidoreductase (3-hydroxylating), EC 1.14.11.1]; the carnitine formed is then measured enzymically. The mean gamma-butyrobetaine content, as nmol/g wet wt. of tissue, ranged from a low of 4.6 in livers to a high of 12.3 in hearts of normal fed male adult rats. Starvation for 48 h did not affect the gamma-butyrobetaine concentration in serum, liver and brain, but that in skeletal muscles, kidney and heart was increased. These data are in line with the present views that most tissues are able to produce gamma-butyrobetaine, and show that starvation enhances the synthesis and/or the retention of this compound in many tissues. The observed high affinity of gamma-butyrobetaine hydroxylase for gamma-butyrobetaine (Km 7 microM), the high activity of this enzyme and the low concentration of gamma-butyrobetaine in liver indicate that gamma-butyrobetaine availability is one of the factors that normally limit carnitine synthesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6466296      PMCID: PMC1153686          DOI: 10.1042/bj2200701

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  [Carnitine content of several biological media].

Authors:  J BROEKHUYSEN; G DELTOUR
Journal:  Ann Biol Clin (Paris)       Date:  1961 Jul-Sep       Impact factor: 0.459

2.  Microdetermination of (-)carnitine and carnitine acetyltransferase activity.

Authors:  R Parvin; S V Pande
Journal:  Anal Biochem       Date:  1977-05-01       Impact factor: 3.365

3.  Enhancement of mitochondrial carnitine and carnitine acylcarnitine translocase-mediated transport of fatty acids into liver mitochondria under ketogenic conditions.

Authors:  R Parvin; S V Pande
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

4.  Cofactor requirements of gamma-butyrobetaine hydroxylase from rat liver.

Authors:  G Lindstedt; S Lindstedt
Journal:  J Biol Chem       Date:  1970-08-25       Impact factor: 5.157

5.  Combined effect of ascorbic acid deficiency and underfeeding on the hepatic carnitine level in guinea-pigs.

Authors:  A Sandor; G Kispal; J Kerner; I Alkonyi
Journal:  Experientia       Date:  1983-05-15

6.  A rapid and sensitive assay of gamma-butyrobetaine hydroxylase.

Authors:  A L Carter; F W Stratman
Journal:  FEBS Lett       Date:  1980-02-25       Impact factor: 4.124

7.  Carnitine and derivatives in rat tissues.

Authors:  D J Pearson; P K Tubbs
Journal:  Biochem J       Date:  1967-12       Impact factor: 3.857

8.  Biosynthesis of carnitine and 4-N-trimethylaminobutyrate from 6-N-trimethyl-lysine.

Authors:  R A Cox; C L Hoppel
Journal:  Biochem J       Date:  1973-12       Impact factor: 3.857

9.  A simplified method for the measurement of gamma-butyrobetaine hydroxylase activity.

Authors:  S Englard; L J Horwitz; J T Mills
Journal:  J Lipid Res       Date:  1978-11       Impact factor: 5.922

10.  Sites and regulation of carnitine biosynthesis in mammals.

Authors:  C J Rebouche
Journal:  Fed Proc       Date:  1982-10
View more
  2 in total

Review 1.  Carnitine biosynthesis in mammals.

Authors:  Frédéric M Vaz; Ronald J A Wanders
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

2.  γ-Aminobutyric acid transporter 2 mediates the hepatic uptake of guanidinoacetate, the creatine biosynthetic precursor, in rats.

Authors:  Masanori Tachikawa; Saori Ikeda; Jun Fujinawa; Shirou Hirose; Shin-ichi Akanuma; Ken-ichi Hosoya
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.